Mice bearing MTCQ1 tumors were treated with 6 fractions at 2 Gy EBRT (Fig. S2) and tumor growth and the profile of CD8a+ T cells, CD80+ M1 macrophages, and CD206+ M2 macrophages was investigated (Fig. 4, S7). This evidence concerns the gene MRC1 and neoplasm.